PubRank

I Terashima

Author PubWeight™ 22.72‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Separate localization of light signal perception for sun or shade type chloroplast and palisade tissue differentiation in Chenopodium album. Plant Cell Physiol 2001 1.24
2 Identification of tamoxifen-DNA adducts in the endometrium of women treated with tamoxifen. Carcinogenesis 2000 1.14
3 Destruction of photosystem I iron-sulfur centers in leaves of Cucumis sativus L. by weak illumination at chilling temperatures. FEBS Lett 1995 1.10
4 [Pharmacokinetic and clinical studies of S-1108 in the pediatric field. Pediatric Study Group of S-1108]. Jpn J Antibiot 1995 1.08
5 Effective utilization of N2-ethyl-2'-deoxyguanosine triphosphate during DNA synthesis catalyzed by mammalian replicative DNA polymerases. Biochemistry 1999 1.03
6 Possible association of actin filaments with chloroplasts of spinach mesophyll cells in vivo and in vitro. Protoplasma 2006 0.99
7 Acclimation of leaf characteristics of Fagus species to previous-year and current-year solar irradiances. Tree Physiol 2000 0.98
8 Synthesis and miscoding specificity of oligodeoxynucleotide containing 8-phenyl-2'-deoxyguanosine. Chem Res Toxicol 1997 0.95
9 Molecular cloning of AtMMH, an Arabidopsis thaliana ortholog of the Escherichia coli mutM gene, and analysis of functional domains of its product. Mol Gen Genet 1998 0.94
10 Mechanism of lower genotoxicity of toremifene compared with tamoxifen. Cancer Res 2001 0.93
11 Cause for dark, chilling-induced inactivation of photosynthetic oxygen-evolving system in cucumber leaves. Plant Physiol 1990 0.90
12 Tamoxifen-DNA adducts detected in the endometrium of women treated with tamoxifen. Chem Res Toxicol 1999 0.89
13 The effect of internal CO2 conductance on leaf carbon isotope ratio. Isotopes Environ Health Stud 2003 0.87
14 Sulfation of alpha-hydroxytamoxifen catalyzed by human hydroxysteroid sulfotransferase results in tamoxifen-DNA adducts. Carcinogenesis 1998 0.85
15 Alpha-hydroxytamoxifen is a substrate of hydroxysteroid (alcohol) sulfotransferase, resulting in tamoxifen DNA adducts. Cancer Res 1998 0.85
16 [Pharmacokinetic and clinical studies with azithromycin (capsule) in the pediatric field. Pediatric Study Group of Azithromycin]. Jpn J Antibiot 1995 0.80
17 Differential inactivation of O6-methylguanine-DNA methyltransferase activity by O6-arylmethylguanines. Int J Cancer 1995 0.80
18 [Pharmacokinetic and clinical studies with azithromycin (fine granule) in the pediatric field. Pediatric Study Group of Azithromycin]. Jpn J Antibiot 1995 0.79
19 Enhancing effect of O6-alkylguanine derivatives on chloroethylnitrosourea cytotoxicity toward tumor cells. Int J Cancer 1994 0.79
20 Effects of virus infection and light environment on population dynamics of Eupatorium makinoi (Asteraceae). Am J Bot 2001 0.77
21 [Clinical studies on clarithromycin dry syrup in the pediatric field. Pediatric Study Group of TE-031 Dry Syrup]. Jpn J Antibiot 1994 0.77
22 Structure and function of plant canopies. Ann Bot 2004 0.77
23 [Clinical studies of arbekacin sulfate in the pediatric field]. Jpn J Antibiot 1994 0.76
24 [Effect of cefditoren pivoxil on carnitine metabolism in pediatric patients]. Jpn J Antibiot 1993 0.76
25 [Trend of bacterial meningitis in children over a 14 year period (1981 through 1994) in Japan--an analysis based on studies in 27 institutions]. Kansenshogaku Zasshi 1997 0.76
26 Enhancement effect of O6-fluorobenzylguanines on chloroethylnitrosourea cytotoxicity in tumor cells. Life Sci 1996 0.76
27 [Guillain-Barré syndrome associated with anti-GQ1b antibody--nosological relationship between Fisher's syndrome and Guillain-Barré syndrome]. Rinsho Shinkeigaku 1994 0.75
28 [Haemophilus influenzae strains resistant to chloramphenicol or to chloramphenicol-ampicillin]. Kansenshogaku Zasshi 1982 0.75
29 [A clinical study on cefditoren pivoxil granules in the pediatric field]. Jpn J Antibiot 1993 0.75
30 [Optimum dose study of cefozopran in the pediatric field]. Jpn J Antibiot 1996 0.75
31 [Clinical evaluation of a new carbapenem antibiotic, biapenem (L-627), in the pediatric field]. Jpn J Antibiot 1994 0.75
32 [Clinical evaluation of panipenem/betamipron in children]. Jpn J Antibiot 1992 0.75
33 [Clinical evaluation of S-1108 in children]. Jpn J Antibiot 1993 0.75
34 [Clinical evaluation of a new carbapenem, meropenem, in infants and children]. Jpn J Antibiot 1992 0.75
35 Potentiation of the cytotoxicity of chloroethylnitrosourea by O6-arylmethylguanines. Biol Pharm Bull 1995 0.75
36 [Study on potentiation of nitrosourea-cytotoxicity by DNA repair enzyme inhibitors in human brain tumor cells]. No To Shinkei 1997 0.75
37 [Clinical evaluation of cefozopran in the pediatric field]. Jpn J Antibiot 1994 0.75
38 [Clinical evaluation of cefdinir 10% granules in children]. Jpn J Antibiot 1991 0.75
39 [Pharmacokinetic and clinical studies of SY5555 in the pediatric field. Pediatric Study Group of SY5555]. Jpn J Antibiot 1994 0.75
40 Identification of tamoxifen-DNA adducts induced by alpha-acetoxy-N-desmethyltamoxifen. Chem Res Toxicol 2000 0.75
41 [Evaluation of two rapid tests for detecting ampicillin-resistant strains of haemophilus influenzae (author's transl)]. Kansenshogaku Zasshi 1981 0.75
42 [Clinical studies of sulbactam/cefoperazone therapy in pediatric bacterial infections]. Jpn J Antibiot 1984 0.75
43 [Clinical evaluation of faropenem against infections in pediatric fields]. Jpn J Antibiot 1997 0.75
44 [A study on compensation technique of casting shrinkage by hygroscopic expansion of mold immersing in hot-water]. Nihon Shika Zairyo Kikai Gakkai Zasshi 1973 0.75
45 The effect of chilling in the light on photophosphorylation : Analysis of discrepancies between in vitro and in vivo results. Photosynth Res 1990 0.75
46 [Antibacterial activities of a carbapenem antibiotic, biapenem (L-627), against penicillin-resistant Streptococcus pneumoniae]. Jpn J Antibiot 1994 0.75
47 [Bacteriological and clinical studies of 6059-S in pediatric infections (author's transl)]. Jpn J Antibiot 1981 0.75
48 Synthesis and O-demethylation rate of cis-[Pt(NH3)2(O6,9-dimethylguanine-7)2]Cl2: a study of the demethylation mechanism of O6-methylguanine-DNA methyltransferase. Chem Res Toxicol 1992 0.75
49 [Pharmacokinetic, bacteriological and clinical studies on cefozopran in neonates and premature infants. A study of cefozopran in the perinatal co-research group]. Jpn J Antibiot 1996 0.75
50 [Influence of dexamethasone on the clinical course of bacterial meningitis in children. Especially on secondary fever. Experiences in 27 institutions]. Kansenshogaku Zasshi 1999 0.75
51 [Clinical studies on cefadroxil in pediatrics (author's transl)]. Jpn J Antibiot 1981 0.75
52 [Clinical evaluation of a new oral penem, SY5555, in the pediatric field]. Jpn J Antibiot 1995 0.75
53 [Clinical evaluation of ceftriaxone in children]. Jpn J Antibiot 1984 0.75
54 [Pharmacokinetic and clinical studies with cefluprenam in the pediatric field. Pediatric Study Group of Gefluprenam]. Jpn J Antibiot 1997 0.75
55 [Clinical studies of 9, 3"-diacetylmidecamycin (author's transl)]. Jpn J Antibiot 1982 0.75
56 Pharmacokinetics and clinical effects of cefozopran in pediatric patients. Jpn J Antibiot 1996 0.75
57 [Atypical course observed following discography--cases of discitis and disappearing backache]. Seikei Geka 1966 0.75
58 [Studies on 145 cases of septicemia in infancy and childhood--especially on septicemic patients with malignant and hematological diseases]. Kansenshogaku Zasshi 1989 0.75
59 Pyogenic liver abscess due to Bacteroides fragilis. Acta Paediatr Jpn 1987 0.75
60 [Pharmacokinetic, bacteriological and clinical studies on cefozopran in neonates]. Jpn J Antibiot 1997 0.75
61 [Clinical evaluation of cefpiramide in 6 cases of infection in children]. Jpn J Antibiot 1983 0.75
62 [Fundamental and clinical studies of ceftazidime in the field of pediatrics]. Jpn J Antibiot 1984 0.75
63 [Pharmacokinetic and clinical studies with cefozopran in the pediatric field. Pediatric Study Group of Cefozopran]. Jpn J Antibiot 1994 0.75
64 [Clinical evaluation of a new macrolide antibiotic, azithromycin, in the pediatric field]. Jpn J Antibiot 1997 0.75
65 [Overall clinical evaluation of panipenem/betamipron against infections in pediatric field]. Jpn J Antibiot 1992 0.75